Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8723712 | Nutrition | 2018 | 42 Pages |
Abstract
In summary, our results indicate that long-term administration of the non-bacterial fraction of kefir promotes a significant decrease in both MAP and HR, by improving baroreflex, and reduces cardiac hypertrophy in SHRs, likely via ACE inhibition, and reduction of the TNF-α-to-IL10 ratio.
Related Topics
Health Sciences
Medicine and Dentistry
Endocrinology, Diabetes and Metabolism
Authors
Girlandia Alexandre Ph.D., Mirian de Almeida M.Sc., Flávia de Souza Andrade M.Sc., Thiago de Melo Costa Ph.D., Elisardo Corral Ph.D., Dominik Ph.D., Nazaré Souza Ph.D., Denise Coutinho Ph.D., Ewelyne Miranda Ph.D., VinÃcia Campana Ph.D.,